Abstract

  A flare-up of unidentified pneumonia in Wuhan since December 2019 has been developed which draw an extraordinary consideration around the globe. Primary reports from Europe and the USA found an association between severe acute respiratory syndrome coronavirus 2 in children and multisystem inflammatory syndrome in children, also known as paediatric inflammatory multisystem syndrome. This study focused on the association between COVID-19 and multisystem inflammatory syndrome in children in the Eastern region of Libya, namely Benghazi a case summary presentation. A series of 12 cases has been described in details. All cases presented with fever, skin and mucous membrane manifestations in addition to GIT symptoms. Three cases have had CNS involvement, three have lymphadenopathy, two cases with cardiac manifestations and two renal with renal involvement. Laboratory data revealed elevated inflammatory markers namely ESR and CRP and lymphopenia. Diagnosis was based on rapid test (IgG, IgM), whereas four cases were diagnosed by PCR. The overall prognosis of all cases is very good with an average hospitalization period of 5 - 7 days. Management strategy included IV antibiotic, oral aspirin and sandoglobulin.

Keywords: Multisystem Inflammatory Syndrome; COVID-19; Paediatric

References

1. Wang LF., et al. “Review of bats and SARS”. Emerging Infectious Diseases 12 (2006): 1834‐1840.
2. Ge XY., et al. “Isolation and characterization of a bat SARS‐like coronavirus that uses the ACE2 receptor”. Nature7477 (2013): 535‐538.
3. Chen Y and Guo D. “Molecular mechanisms of coronavirus RNA capping and methylation”. Virologica Sinica 1 (2016): 3‐11.
4. Yu Chen., et al. “Emerging coronaviruses: Genome structure, replication, and Pathogenesis”. Journal of Medical Virology 92 (2020): 418-423.
5. https://www.worldometers.info/coronavirus/?fbclid=IwAR06Vni6sH4IvRyiJwF98kMUV-
6. The National Center for Control of Diseases/Libya (2020).
7. Wang D., et al. “Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China”. The Journal of the American Medical Association (2020).
8. Dong Y., et al. “Epidemiology of COVID-19 among children in China”. Pediatrics6 (2020): e20200702.
9. Heimdal I., et al. “Human coronavirus in hospitalized children with respiratory tract infections: a 9-year population-based study from Norway”. The Journal of Infectious Diseases 8 (2019): 1198-1206.
10. Massod Sadiq. “Multisystem inflammatory syndrome associated with COVID-19 in children in Pakistan (2020).
11. Riphagen S., et al. “Hyper inflammatory shock in children during COVID-19 pandemic”. Lancet 395 (2020): 1607.
12. Davies P., et al. “Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicenter observational study”. The Lancet Child and Adolescent Health (2020).
13. Riphagen S., et al. “Hyperinflammatory shock in children during COVID-19 pandemic”. Lancet (2020).
14. Ontario Agency for Health Protection and Promotion (Public Health Ontario). COVID-19 - What we know so far about...Kawasaki disease-like illness. Toronto, ON: Queens’s Printer for Ontario (2020).
15. Kuo HC., et al. “Kawasaki Disease: An Update on Diagnosis and Treatment”. Pediatrics and Neonatology 53 (2012): 4-11.
16. Cascella M., et al. “Features, Evaluation and Treatment Coronavirus (COVID-19). Stat Pearls”. Treasure Island (FL) (2020).
17. Siddiqi HK and Mehra MR. “COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal”. The Journal of Heart and Lung Transplantation 5 (2020): 405-407.
18. Kuo HC., et al. “Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease”. Acta Paediatrica 99 (2010): 1578-1583.
19. Bajolle F and Laux D. “Kawasaki disease: what you need to know [in French]”. Acta Paediatrica 19 (2012): 1264-1268.
20. Nakamura Y., et al. “Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey”. Journal of Epidemiology 3 (2012): 216-221.
21. Merzouk S. “La Maladie de Kawasaki [These]”. Medecine: Maroc. Universite Sidi Mohammed Ben Abdellah, Faculte de Medecine et de Pharmacie, Fes (2010).
22. Usta Guc B., et al. “Cytomegalovirus infection in a patient with atypical Kawasaki disease”. Rheumatology International4 (2008): 387-389.
23. Kuijpers TW., et al. “Kawasaki disease: a maturational defect in immune responsiveness”. The Journal of Infectious Diseases 180 (1999): 1869-1877.
24. Gorrab AA., et al. “Incidence Rate and Epidemiological and Clinical Aspects of Kawasaki Disease in Children of Maghrebi Origin in the Province of Quebec, Canada, Compared to the Country of Origin”. Global Pediatric Health (2016).

Citation

Citation: Raga Elfakhrei., et al. "COVID-19 Pandemic and Increased Frequency of Multisystem Inflammatory Syndrome in Children/Benghazi 2020". Acta Scientific Paediatrics 3.12 (2020): 13-18.

Copyright

Copyright: © 2020 Raga Elfakhrei., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.